Cargando…
Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population
AIM: Multigene panel testing for Hereditary Breast and Ovarian Cancer (HBOC) using next generation sequencing is becoming more common in medical care. We report our experience regarding deleterious mutations of high and moderate-risk breast cancer genes (BRCA1/2, TP53, STK11, CDH1, PTEN, PALB2, CHEK...
Autores principales: | GOIDESCU, IULIAN GABRIEL, CARACOSTEA, GABRIELA, ENIU, DAN TUDOR, STAMATIAN, FLORIN VASILE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958980/ https://www.ncbi.nlm.nih.gov/pubmed/29785153 http://dx.doi.org/10.15386/cjmed-894 |
Ejemplares similares
-
Spectrum of High-Risk Mutations among Breast Cancer Patients Referred for Multigene Panel Testing in a Romanian Population
por: Goidescu, Iulian Gabriel, et al.
Publicado: (2023) -
Umbilical Cord Biometry and Fetal Abdominal Skinfold Assessment as Potential Biomarkers for Fetal Macrosomia in a Gestational Diabetes Romanian Cohort
por: Florian, Andreea Roxana, et al.
Publicado: (2022) -
Killer Cell Immunoglobulin-like Receptor Genotypes and Reproductive Outcomes in a Group of Infertile Women: A Romanian Study
por: Surcel, Mihai, et al.
Publicado: (2023) -
Spectrum of BRCA1/2 Mutations in Romanian Breast and Ovarian Cancer Patients
por: Vidra, Radu, et al.
Publicado: (2022) -
Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)